Tracking a year of COPD care: does a triple therapy deliver?
NCT ID NCT06712563
Summary
This study looks back at data from real-world patients with moderate to severe COPD who started a triple-combination inhaler (BGF). It aims to see how their symptoms, quality of life, and number of flare-ups change over 12 months compared to before starting the treatment. The goal is to understand how well this medication works in everyday clinical practice, not in a controlled trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGMississauga, Canada
-
Research Site
RECRUITINGHamburg, Germany
-
Research Site
RECRUITINGAthens, Greece
-
Research Site
RECRUITINGMilan, Italy
-
Research Site
RECRUITINGTokyo, Japan
-
Research Site
NOT_YET_RECRUITINGBucharest, Romania
-
Research Site
RECRUITINGLondon, United Kingdom
Conditions
Explore the condition pages connected to this study.